Evidence map›Paper›PMID 10531264›Full record

ArticleInfection and immunity1999

Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages.

L Liu, R P Tewari, P R Williamson

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 185 citations in OpenAlex.

  1. A Putative Multicopper Oxidase Encoded byInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Virulence factors released by extracellular vesicles fromFrontiers in cellular and infection microbiology · 2025
    Review
  8. Measuring Laccase Activity and Melanin Production in Cryptococcus neoformans.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. Journal of fungi (Basel, Switzerland) · 2022
    Review
  13. Article
  14. FasterJournal of fungi (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Antifungal activity of liriodenine on clinical strains ofThe journal of venomous animals and toxins including tropical diseases · 2022
    Article
  17. Macrophage Mediated Immunomodulation DuringFrontiers in cellular and infection microbiology · 2022
    Review
  18. Article
  19. Review
  20. Future microbiology · 2021
    Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

L LiuDivision of Infectious Diseases, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
R P Tewari
P R Williamson
University of Illinois Chicago · USSouthern Illinois University School of Medicine · US

Funding

CNLAC 1 AND THE VIRULENCE OF CRYPTOCOCCUSR29AI038258 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WILLIAMSON, PETER RICHARD · 1996 to 2000
$105k
NIAID NIH HHS AI38258
6 · The paper itself

Abstract

While laccase of Cryptococcus neoformans is implicated in the virulence of the organism, our recent studies showing absence of melanin in the infected mouse brain has led us to a search for alternative roles for laccase in cryptococcosis. We investigated the role of laccase in protection of C. neoformans against murine alveolar macrophage (AM)-mediated antifungal activity by using a pair of congenic laccase-positive (2E-TUC) and laccase-deficient (2E-TU) strains. The laccase-positive cells with laccase derepression were more resistant to the antifungal activity of AM than a laccase-deficient strain ([28.9 +/- 1.2]% versus [40.2 +/- 2.6]% killing). Addition of L-dopa to Cryptococcus to produce melanin in a laccase-positive strain resulted in a slight increase in protection of C. neoformans from the antifungal activity of macrophages ([25.4 +/- 3.4]% versus [28.9 +/- 1.2]% killing). Recombinant cryptococcal laccase exhibited iron oxidase activity in converting Fe(II) to Fe(III). Moreover, recombinant laccase inhibited killing of C. neoformans by hydroxyl radicals catalyzed by iron in a cell-free system. Addition of the hydroxyl radical scavenger mannitol or dimethyl sulfoxide to AMs prior to the introduction of cryptococcal cells decreased killing of both strains and reduced the difference in susceptibility between the laccase-positive and laccase-deficient strains. Furthermore, laccase-mediated protection from AM killing was inhibited by the addition of Fe(II), presumably by overcoming the effects of the iron oxidase activity of cryptococcal laccase. These results suggest that the iron oxidase activity of laccase may protect C. neoformans from macrophages by oxidation of phagosomal iron to Fe(III) with a resultant decrease in hydroxyl radical formation.

Indexed as

AnimalsCryptococcus neoformansFemaleHydroxyl RadicalIronLaccaseMacrophages, AlveolarMiceMolsidomineOxidoreductasesPhagocytosisRecombinant ProteinsHydroxyl RadicalIronLaccaselinsidomineMolsidomineOxidoreductasesRecombinant Proteins

Identifiers

PMID10531264
PMCPMC96990
OpenAlexW2143063605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.